Hemmi T, Ainai A, Hashiguchi T, Tobiume M, et al. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology. Vaccine 2022 Aug 26. pii: S0264-410X(22)01038.
PMID: 36064667